Vioxx Research - Osteoarthritis, Side-effects, Trials, Stroke, Heart Attack

Vioxx Research Today is a free monthly online journal that collates and summarizes the latest research about Vioxx, including details on osteoarthritis, side-effects, trials, stroke, heart attack.


Vioxx Research Today

Home

View Latest Issue

Information About Vioxx

Books on Vioxx

Advertising in Research Today

View Other Research Today Publications



Volume 2 (2005), Issue 1 (January)

  1. Rofecoxib for osteoarthritis.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
  2. Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model.
    Fertil Steril, 83(1): 171-81. [Abstract] [Full-text]
  3. COX expression and PGE(2) and PGD(2) production in experimental acute and chronic gastric lesions.
    Int Immunopharmacol, 5(2): 369-79. [Abstract] [Full-text]
  4. Preemptive rofecoxib and dexamethasone for prevention of pain and trismus following third molar surgery *.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 99(2): E1-7. [Abstract] [Full-text]
  5. The effects of selective cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, on experimental colitis induced by acetic acid in rats.
    Eur J Pharmacol, 507(1): 291-9. [Abstract] [Full-text]
  6. Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: a randomized, double blinded, placebo controlled crossover trial in the UV-B pain model.
    Pain, 113(3): 316-22. [Abstract] [Full-text]
  7. Simultaneous LC determination of tizanidine and rofecoxib in tablets.
    J Pharm Biomed Anal, 37(1): 183-5. [Abstract] [Full-text]
  8. Application of HPLC and HPTLC for the simultaneous determination of tizanidine and rofecoxib in pharmaceutical dosage form.
    J Pharm Biomed Anal, 37(1): 27-38. [Abstract] [Full-text]
  9. Intracranial hypertension induced by rofecoxib.
    Headache, 45(1): 75-6. [Abstract] [Full-text]
  10. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors.
    Arch Intern Med, 165(2): 189-92. [Abstract] [Full-text]
  11. National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation.
    Arch Intern Med, 165(2): 171-7. [Abstract] [Full-text]
  12. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Arch Intern Med, 165(2): 161-8. [Abstract] [Full-text]
  13. Single dose oral rofecoxib for postoperative pain.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
  14. Rofecoxib for rheumatoid arthritis.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
  15. Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitors.
    Eur J Clin Pharmacol. [Abstract] [Full-text]
  16. Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension.
    Hypertension, 45(2): 193-7. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2014 Vioxx Research Today. All Rights Reserved.



Vioxx Research Today Archive:

Volume 1 (2004)
  Issue 1 (November)
  Issue 2 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 10 (2013)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 11 (2014)
  Issue 1 (January)
  Issue 2 (February)



Vioxx Books

Clinical Trials in Rheumatoid Arthritis and Osteoarthritis

Clinical Trials in Rheumatoid Arthritis and Osteoarthritis